Sixteen capillary electrophoresis applications for viral vaccine analysis.

Autor: Geurink L; Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands.; Department of Medicinal Chemistry, Faculty of Pharmacy, Biomedical Centre, Uppsala University, Uppsala, Sweden., van Tricht E; Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands., van der Burg D; Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands., Scheppink G; Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands., Pajic B; Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands., Dudink J; Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands., Sänger-van de Griend C; Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands.; Department of Medicinal Chemistry, Faculty of Pharmacy, Biomedical Centre, Uppsala University, Uppsala, Sweden.; Kantisto B.V., Baarn, The Netherlands.
Jazyk: angličtina
Zdroj: Electrophoresis [Electrophoresis] 2022 May; Vol. 43 (9-10), pp. 1068-1090. Date of Electronic Publication: 2021 Nov 21.
DOI: 10.1002/elps.202100269
Abstrakt: A broad range of CE applications from our organization is reviewed to give a flavor of the use of CE within the field of vaccine analyses. Applicability of CE for viral vaccine characterization, and release and stability testing of seasonal influenza virosomal vaccines, universal subunit influenza vaccines, Sabin inactivated polio vaccines (sIPV), and adenovirus vector vaccines were demonstrated. Diverse CZE, CE-SDS, CGE, and cIEF methods were developed, validated, and applied for virus, protein, posttranslational modifications, DNA, and excipient concentration determinations, as well as for the integrity and composition verifications, and identity testing (e.g., CZE for intact virus particles, CE-SDS application for hemagglutinin quantification and influenza strain identification, chloride or bromide determination in process samples). Results were supported by other methods such as RP-HPLC, dynamic light scattering (DLS), and zeta potential measurements. Overall, 16 CE methods are presented that were developed and applied, comprising six adenovirus methods, five viral protein methods, and methods for antibodies determination of glycans, host cell-DNA, excipient chloride, and process impurity bromide. These methods were applied to support in-process control, release, stability, process- and product characterization and development, and critical reagent testing. Thirteen methods were validated. Intact virus particles were analyzed at concentrations as low as 0.8 pmol/L. Overall, CE took viral vaccine testing beyond what was previously possible, improved process and product understanding, and, in total, safety, efficacy, and quality.
(© 2021 Janssen Vaccines & Prevention B.V. Electrophoresis published by Wiley-VCH GmbH.)
Databáze: MEDLINE
Externí odkaz: